Omnipod 5 DEXG7G6 pods (GEN 5) 5S
Ended Awarded Last action
- Contract number
- SPE2DR26FR8YE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $75,389
Award facts
- Contract value 100% obligated
- $75,388.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $75,388.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pump pods. The award was made on January 12, 2026, with an ultimate completion date of January 13, 2026, and represents a non-set-aside, competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the company's primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, operates as a subsidiary of its parent company Cencora, Inc. (doing business as AmerisourceBergen). The company has demonstrated consistent capability in fulfilling federal medical procurement needs across multiple therapeutic domains, including diabetes management products like the OmniPod insulin delivery system. DLA Troop Support Medical utilizes AmerisourceBergen's prime vendor contract to supply critical medical commodities including specialty medications, vaccines, and medical devices to military treatment facilities and veterans' healthcare programs worldwide, supporting the broader Defense Health Agency mission to maintain pharmaceutical supply chain readiness for the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26FR8YE?
SPE2DR26FR8YE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FR8YE worth?
The government has obligated $75,389 on SPE2DR26FR8YE.
Is contract SPE2DR26FR8YE an order under another contract?
Yes. SPE2DR26FR8YE is a delivery order under SPE2DR25D3018, an indefinite delivery contract.
Was contract SPE2DR26FR8YE competed?
The extent of competition for SPE2DR26FR8YE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award